Free Trial
NYSE:FMS

Fresenius Medical Care AG & Co. KGaA (FMS) Stock Price, News & Analysis

Fresenius Medical Care AG & Co. KGaA logo
$27.07 +0.25 (+0.93%)
Closing price 10/8/2025 03:59 PM Eastern
Extended Trading
$27.27 +0.20 (+0.75%)
As of 10/8/2025 05:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Fresenius Medical Care AG & Co. KGaA Stock (NYSE:FMS)

Advanced

Key Stats

Today's Range
$26.92
$27.48
50-Day Range
$23.49
$27.07
52-Week Range
$18.94
$30.46
Volume
301,318 shs
Average Volume
338,144 shs
Market Capitalization
N/A
P/E Ratio
22.19
Dividend Yield
2.11%
Price Target
$27.80
Consensus Rating
Hold

Company Overview

Fresenius Medical Care AG & Co. KGaA Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

FMS MarketRank™: 

Fresenius Medical Care AG & Co. KGaA scored higher than 76% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Fresenius Medical Care AG & Co. KGaA has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on 2 buy ratings, 2 hold ratings, and 2 sell ratings.

  • Upside/Downside

    The consensus price target for Fresenius Medical Care AG & Co. KGaA is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Fresenius Medical Care AG & Co. KGaA has only been the subject of 4 research reports in the past 90 days.

  • Read more about Fresenius Medical Care AG & Co. KGaA's stock forecast and price target.
  • Earnings Growth

    Earnings for Fresenius Medical Care AG & Co. KGaA are expected to grow by 27.15% in the coming year, from $1.51 to $1.92 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 22.19, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 234.02.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 22.19, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.48.

  • Price to Earnings Growth Ratio

    Fresenius Medical Care AG & Co. KGaA has a PEG Ratio of 0.61. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Fresenius Medical Care AG & Co. KGaA has a P/B Ratio of 0.93. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Fresenius Medical Care AG & Co. KGaA's valuation and earnings.
  • Percentage of Shares Shorted

    0.26% of the float of Fresenius Medical Care AG & Co. KGaA has been sold short.
  • Short Interest Ratio / Days to Cover

    Fresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 4.8.
  • Change versus previous month

    Short interest in Fresenius Medical Care AG & Co. KGaA has recently increased by 3.47%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Fresenius Medical Care AG & Co. KGaA pays a meaningful dividend of 2.13%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Fresenius Medical Care AG & Co. KGaA does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 46.72%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 29.69% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend.

  • Read more about Fresenius Medical Care AG & Co. KGaA's dividend.
  • Percentage of Shares Shorted

    0.26% of the float of Fresenius Medical Care AG & Co. KGaA has been sold short.
  • Short Interest Ratio / Days to Cover

    Fresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 4.8.
  • Change versus previous month

    Short interest in Fresenius Medical Care AG & Co. KGaA has recently increased by 3.47%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Fresenius Medical Care AG & Co. KGaA has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Fresenius Medical Care AG & Co. KGaA this week, compared to 3 articles on an average week.
  • Search Interest

    3 people have searched for FMS on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Fresenius Medical Care AG & Co. KGaA to their MarketBeat watchlist in the last 30 days.
Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FMS Stock News Headlines

Shots officially fired…
Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the rights to deliver direct-to-cell service nationwide — a move tech analyst Jeff Brown says could shape the backbone of the coming space economy and create fortunes on a scale not seen since the rise of NVIDIA.tc pixel
See More Headlines

FMS Stock Analysis - Frequently Asked Questions

Fresenius Medical Care AG & Co. KGaA's stock was trading at $22.64 at the beginning of 2025. Since then, FMS shares have increased by 19.6% and is now trading at $27.07.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) posted its quarterly earnings results on Tuesday, August, 5th. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.02. The firm earned $5.54 billion during the quarter, compared to the consensus estimate of $5 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 3.39% and a trailing twelve-month return on equity of 6.75%.
Read the conference call transcript
.

Fresenius Medical Care AG & Co. KGaA subsidiaries include NxStage Medical.

Top institutional investors of Fresenius Medical Care AG & Co. KGaA include Balefire LLC, GAMMA Investing LLC and Veracity Capital LLC.

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius Medical Care AG & Co. KGaA investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Energy Transfer (ET), AbbVie (ABBV), GE Aerospace (GE) and Adobe (ADBE).

Company Calendar

Last Earnings
8/05/2025
Today
10/08/2025
Next Earnings (Estimated)
11/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Healthcare
Current Symbol
NYSE:FMS
CIK
1333141
Employees
1,384
Year Founded
1912

Price Target and Rating

High Price Target
$30.00
Low Price Target
$25.60
Potential Upside/Downside
+2.9%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.22
Trailing P/E Ratio
22.13
Forward P/E Ratio
17.89
P/E Growth
0.61
Net Income
$582.08 million
Net Margins
3.39%
Pretax Margin
5.98%
Return on Equity
6.75%
Return on Assets
3.13%

Debt

Debt-to-Equity Ratio
0.44
Current Ratio
1.44
Quick Ratio
1.08

Sales & Book Value

Annual Sales
$20.63 billion
Price / Sales
N/A
Cash Flow
$4.92 per share
Price / Cash Flow
5.49
Book Value
$29.08 per share
Price / Book
0.93

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Optionable
Beta
0.92

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:FMS) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners